Veeva
Veeva Systems provides cloud-based software for the global life sciences industry, serving 1,500+ customers including 15 of the top 20 biopharma companies across clinical, regulatory, safety, quality, and commercial operations on its Veeva Vault Platform.
- Company typePublic
- Founded2007
- HeadquartersPleasanton, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Veeva does
Veeva Systems is a public cloud software company (NYSE: VEEV) founded in 2007 and headquartered in Pleasanton, California, that builds industry-specific applications for the global life sciences sector. The company operates the Veeva Vault Platform — a validated, regulated cloud infrastructure powering five product clouds: Veeva Development Cloud (clinical, eTMF, CTMS, RTSM, EDC, CDB, eCOA), Veeva Regulatory (RIM, Submissions), Veeva Safety Suite (pharmacovigilance), Veeva Quality Cloud (QMS, Training, LIMS, Batch Release, plus new EHS module), and Veeva Commercial Cloud (Vault CRM Suite, Ostro, Campaign Manager, Events Management, PromoMats, Align, Patient CRM). Supporting layers include the Veeva Data Cloud (OpenData, Link, Compass, Crossix) and a growing AI portfolio (Vault AI, Veeva Falcon, Veeva Falcon MLR). The company serves more than 1,500 customers across pharma, biotech, MedTech, consumer health, and CDMOs, including 15 of the top 20 global biopharma companies, with 4,000+ active Vault instances and 2M+ monthly active users.
Veeva's go-to-market is direct enterprise field sales targeting life sciences organizations through multi-year subscription contracts; the company maintains 5,001-10,000 employees and operates globally across North America, Europe, Asia Pacific, Latin America, and the Middle East. Revenue is overwhelmingly recurring — approximately 89% subscription, with subscription revenue of $730.2M in Q1 FY2027 (15% YoY) and total Q1 FY2027 revenue of $882.9M (16% YoY). Full-year FY2026 revenue was $3.195B and management has guided FY2027 to $3.635-3.645B. The Vault CRM Suite shows particularly strong momentum, with 140 customers live as of May 2026 (up from 125+ earlier in the year), 27 new customers added in Q1 FY2027, and an 80%+ competitive win rate.
The company pursues an aggressive AI- and acquisition-led growth strategy. Three acquisitions were completed in 2026 — Yonalink (clinical data, February), Ostro (AI brand engagement, ~$100M, March), and Copli (agentic MLR, rebranded as Veeva Falcon MLR, June) — alongside major product launches including Veeva Falcon (agentic platform, November 2026 early access) and Veeva EHS (August 2026). Veeva was added to the S&P 500 index on May 7, 2026, and the company operates as a Public Benefit Corporation under CEO and founder Peter Gassner. Strategic data ecosystem partnerships with Snowflake (Openflow Connector) and Databricks (Genie AI agents embedded in Vault CRM) extend the platform into customer data architectures, signaling a deliberate positioning as the workflow and AI orchestration layer for life sciences.
Veeva firmographics
Firmographics- Name
- Veeva
- Legal name
- Veeva Systems Inc.
- Website
- https://veeva.com
- Company type
- Public
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Veeva Systems provides cloud-based software for the global life sciences industry, serving 1,500+ customers including 15 of the top 20 biopharma companies across clinical, regulatory, safety, quality, and commercial operations on its Veeva Vault Platform.
- Ownership category
- akta.pro rank
Veeva industry classification
Industry- Product category
- Life Sciences Cloud Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Industry/Vertical Cloud Platforms (e.g., Gov/Healthcare/Financial Cloud Regions) (HDABAAAL)
Keywords
Where Veeva is headquartered
LocationHeadquarters
- HQ city
- Pleasanton
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Veeva business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Subscription Revenue: Veeva generates the majority of its revenue (approximately 89% of total) from subscription-based software licenses for its Vault platform applications. Customers pay annual or multi-year subscription fees based on the number of users, applications deployed, and contract value. Subscription revenue grew 15% year-over-year to $730.2 million in Q1 FY2027.
- Professional Services: Implementation, consulting, and training services to help customers deploy and optimize Veeva applications. Professional services contributed $101.3 million in Q1 FY2026, representing approximately 11% of total revenue.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise Subscription Licensing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Veeva product offering
Product offeringCore offering
Veeva Systems provides the industry cloud for life sciences, delivering cloud-based software on the Veeva Vault Platform for pharmaceutical, biotech, and MedTech organizations. The portfolio spans Veeva Development Cloud (clinical, regulatory, safety), Veeva Quality Cloud, Veeva Medical Suite, and Veeva Commercial Cloud (CRM and engagement), supported by data products and AI capabilities including Vault AI, Veeva Falcon, and Ostro. Approximately 89% of revenue comes from subscription fees, with the remainder from professional services.
Product overview
Veeva Systems provides a comprehensive industry cloud platform for life sciences, operating as a unified platform-plus-modules architecture. The portfolio spans five core clouds: Veeva Development Cloud (encompassing Veeva Clinical Platform, eTMF, CTMS, RTSM, EDC, CDB, eCOA), Veeva Regulatory (RIM, Registrations, Submissions), Veeva Safety Suite (Safety, SafetyDocs, Safety Signal, Safety Workbench), Veeva Quality Cloud (QualityDocs, QMS, Training, LIMS, Validation Management, Batch Release), and Veeva Commercial Cloud (Vault CRM Suite, Ostro, Campaign Manager, Events Management, Align, Patient CRM, PromoMats, Nitro). Supporting these are data products (OpenData, Veeva Link, Veeva Compass) and AI capabilities (Vault AI, Veeva Falcon, Veeva Falcon MLR). The platform serves pharma, biotech, MedTech, and other life sciences organizations across clinical, regulatory, quality, medical, and commercial operations.
Differentiator
Problem solved
Functional benefit
Brands
- Veeva Vault: The company's cloud-based platform for life sciences applications
- Veeva Development Cloud
- Veeva Quality Cloud
- Veeva Commercial Cloud
- Veeva Safety Suite
- Veeva RIM
- Veeva Medical Suite
- Ostro
- Veeva Falcon
- Veeva Falcon MLR
- Veeva EHS
- Veeva AI
- Veeva Crossix
- SiteVault
- Veeva OpenData
- Veeva Link
- Veeva Compass
- QualityOne
Products and services
- Veeva Vault Platform
- Veeva Development Cloud
- Veeva Clinical Platform
- Veeva eTMF
- Veeva CTMS
- Veeva RTSM
- Veeva EDC
- Veeva CDB
- Veeva eCOA
- Veeva RIM
- Veeva Submissions
- Veeva Safety Suite
- Veeva Safety
- Veeva Safety Signal
- Veeva Quality Cloud
- Veeva QualityDocs
- Veeva QMS
- Veeva Training
- Veeva LIMS
- Veeva Medical Suite
- Veeva Vault CRM Suite
- Ostro AI-powered brand engagement platform providing instant compliant answers for patients and HCPs using conversational AI and semantic search drawn from MLR-approved materials; trusted by 50% of the Top 20 global pharmaceutical companies.
- Veeva Campaign Manager Marketing automation application for coordinating sales and marketing engagement in unified campaigns using both non-personal and field channels with segmented, multi-action campaigns.
- Veeva Events Management
- Veeva Align
- Veeva Patient CRM
- Veeva PromoMats
- Veeva Nitro
- Veeva OpenData
- Veeva Link
- Veeva Compass
- Vault AI
- Veeva Falcon Agentic platform with standard agents for life sciences drug development processes including trial master file document intake, health authority correspondence, and safety case triage; Veeva's first offering in 'agentic labor' for the industry.
- Veeva Falcon MLR Agentic Medical, Legal, and Regulatory content-review platform that automates promotional and medical material reviews against approved labels and local regulations, aiming to eliminate over 70% of manual MLR work within five years.
- Veeva EHS Environmental, Health, and Safety management application within Veeva Quality Cloud for proactive risk identification and mitigation while ensuring compliance with global requirements.
- SiteVault
Quantifiable outcome
- 50% faster time to market for promotional content
- +9 more outcomes
Companies that use Veeva
Customer profileNamed customers20 records
Segments5 records
Ideal customer profiles3 records
Veeva technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability8 records
Feature9 records
Veeva partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and major.
- CoplicoreVeeva acquired Copli, a Copenhagen-based pioneer in agentic medical, legal, and regulatory (MLR) solutions for the life sciences industry. Copli was rebranded as Veeva Falcon MLR, an agentic automation solution that automates promotional and medical material reviews against approved labels and local regulations.
- ELIQUENT Life SciencescoreELIQUENT Life Sciences announced the June 1 go-live of Veeva Safety Suite at UCB, marking one of the first deployments of the complete suite globally. The transformation unified UCB's pharmacovigilance operations across case processing, signal management, and reporting into a single cloud-based platform. ELIQUENT led the implementation as the strategic collaboration partner.
- Daelight SolutionsmajorDaelight Solutions was part of the strategic collaboration delivering Veeva Safety Suite at UCB, migrating 14 million documents and 80 million records into the single cloud-based platform.
- PinnaxismajorPinnaxis was part of the strategic collaboration delivering Veeva Safety Suite at UCB, providing implementation services for the pharmacovigilance transformation.
- DatabrickscoreDatabricks and Veeva integrated their platforms to enable life sciences commercial teams to access real-time AI-powered insights directly within Veeva Vault CRM workflows. The integration embeds Databricks Genie AI agents and AI/BI dashboards into the CRM, allowing field teams to query patient signals, HCP prioritization data, KOL information, and territory analytics on demand.
- Accumulus TechnologiescoreAccumulus Technologies announced live integration with Veeva RIM, creating real-time connection between Veeva's regulatory information management system and the Accumulus platform for global health authority collaboration. The integration enables life sciences companies to manage regulatory interactions directly within their existing Veeva RIM environment, eliminating manual reconciliation and system switching. Amgen is among the first companies to deploy the solution.
- SnowflakecoreSnowflake and Veeva announced a collaboration to connect Snowflake's AI Data Cloud for Healthcare & Life Sciences with the Veeva Vault Platform via a new Openflow Connector. The connector enables organizations to access read-only Veeva data within Snowflake to run analytics and AI workflows across clinical, safety, regulatory, quality, and commercial operations without heavy engineering effort. This partnership advances agentic AI adoption in life sciences by bridging business process execution and enterprise data.
- Veracity LogiccoreVeeva acquired Veracity Logic, a provider of cloud software for randomization and trial supply management (RTSM), to enhance its clinical offerings. The combined solutions support over 175 trials across 60 countries and serve multiple therapeutic areas in pharma, biotech, medical devices, and diagnostics.
- LearnaboutgmpmajorVeeva acquired Learnaboutgmp, a provider of GxP training content for the life sciences industry, to enhance its training solutions within its Vault Training platform. The acquisition aims to improve compliance and training outcomes for customers.
- OstrocoreVeeva acquired Ostro in March 2026 for approximately $100 million. Ostro is a brand engagement platform for life sciences providing AI-driven chat experiences that allow patients and doctors to receive compliant, real-time answers from approved materials. Ostro operates as an independent unit within Veeva and will integrate with Veeva Commercial Cloud applications.
- BioMarincoreVeeva and BioMarin formed a long-term strategic partnership combining scientific capabilities with Veeva's technological leadership to bring transformative medicines more quickly to patients. BioMarin is expanding its use of Veeva's cloud platform across clinical, regulatory, and commercial operations.
- RochecoreRoche expanded its strategic relationship with Veeva, committing to Vault CRM for personalized interactions that help teams better support healthcare professionals and patients. The partnership includes embedded AI capabilities for commercial execution.
- Novo NordiskcoreNovo Nordisk International Operations committed to Veeva Vault CRM to empower global teams with next-generation CRM capabilities and agentic AI. The platform will help drive commercial execution for Novo Nordisk's global operations.
Scale indicators23 records
Recent moves7 records
Expansion highlights6 records
Veeva competitors and assessment
Company assessmentMarket position
Competitive moat7 records
Key highlights7 records
Customer concentration
Veeva social profiles
Digital presenceVeeva compliance and trust
Trust signalCompliance4 records
Veeva financial estimates
Financial estimateRevenue estimate
Valuation estimate
Veeva leadership team
Management profileNumber of profiles
Profiles12 records
Veeva subsidiaries and ownership
Company hierarchySubsidiaries4 records
Veeva funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Veeva M&A and investment
M&A and investmentM&A9 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Veeva
What does Veeva do?
Veeva Systems provides the industry cloud for life sciences, delivering cloud-based software on the Veeva Vault Platform for pharmaceutical, biotech, and MedTech organizations. The portfolio spans Veeva Development Cloud (clinical, regulatory, safety), Veeva Quality Cloud, Veeva Medical Suite, and Veeva Commercial Cloud (CRM and engagement), supported by data products and AI capabilities including Vault AI, Veeva Falcon, and Ostro. Approximately 89% of revenue comes from subscription fees, with the remainder from professional services.
Is Veeva a public or private company?
Veeva is a public company. It is classified as public and is currently operating.
When was Veeva founded?
Veeva was founded in 2007. It employs 51 to 100 people.
Where is Veeva based?
Veeva is headquartered in Pleasanton, United States, in the North America region.
How does Veeva make money?
Two revenue lines are on record. Subscription Revenue is the primary driver. The others are professional Services.
Does Veeva have an API?
Yes. Veeva offers an Openflow Connector that enables organizations to access read-only Veeva data within Snowflake for end-to-end analytics and AI workflows across clinical, safety, regulatory, quality, and commercial operations. The Snowflake Openflow Connector allows import of Veeva data into Snowflake for analytics and AI purposes while maintaining data integrity and compliance within Veeva's validated system. Developer documentation is at www.veeva.com/products/vault-platform.
What industry is Veeva in?
Veeva's product category is Life Sciences Cloud Software. Its primary akta.pro industry code is HDABAAAL, Industry/Vertical Cloud Platforms (e.g., Gov/Healthcare/Financial Cloud Regions). Its NAICS code is 513210 and its SIC code is 7372.